迈博药业有限公司（股票代码：02181）于2026年7月3日提交了截至2026年6月30日的股份变动月报表。报告显示，公司6月底的注册股本仍为50,000,000,000股普通股，每股面值为0.0001美元，总注册股本5,000,000美元，与上个月持平。已发行股份总数维持在4,124,080,000股，库存股份为0股，公司表示满足联交所要求的公众持股量。
月报表同步披露，公司当前拥有一项于2018年8月10日批准设立的购股权计划，涉及72,670,876份股份期权。截至本月末，该期权数量未发生变化，当月亦未发行新的股份或进行回购及注销操作，股本整体保持稳定。
本次公告由公司秘书曾浩贤先生签署。公司表示，将持续遵守香港联合交易所有限公司证券上市规则及相关法律法规，并按要求披露后续进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.